Assessing Guardant Health: Insights From 7 Financial Analysts
Portfolio Pulse from Benzinga Insights
Guardant Health (NASDAQ:GH) has received mixed ratings from 7 analysts, with 6 bullish and 1 somewhat bullish ratings in the latest quarter. The average 12-month price target is $34.29, down 6.69% from the previous $36.75. Analysts have adjusted their ratings and price targets based on recent developments.
July 17, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Guardant Health has received a mix of bullish and somewhat bullish ratings from analysts, with an average 12-month price target of $34.29, a decrease from the previous $36.75. Analysts have adjusted their ratings and price targets based on recent developments.
The mixed ratings and the decrease in the average price target suggest a neutral short-term impact on Guardant Health's stock price. While there is a majority of bullish ratings, the lowered price target indicates tempered expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100